We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RHT
301
DELISTED
Red Hat Inc
RHT
| $29M | 0.07% |
335,607
+8,124
| +2% | +$646K |
|
302
W.W. Grainger
GWW
$64.2B
| $29M | 0.07% |
124,675
+3,323
| +3% | +$818K |
|
|
XLNX
303
DELISTED
Xilinx Inc
XLNX
| $28.9M | 0.07% |
498,509
+10,746
| +2% | +$632K |
|
|
VIAB
304
DELISTED
Viacom Inc. Class B
VIAB
| $28.8M | 0.07% |
618,340
-6,969
| -1% | -$294K |
|
305
KLA
KLAC
$222B
| $28.7M | 0.07% |
3,019,240
+78,220
| +3% | +$689K |
|
306
Cencora
COR
$62B
| $28.5M | 0.07% |
322,539
+3,594
| +1% | +$316K |
|
307
Motorola Solutions
MSI
$72.1B
| $28.5M | 0.07% |
330,639
+9,375
| +3% | +$766K |
|
308
Healthpeak Properties
DOC
$15.5B
| $28.2M | 0.07% |
901,438
+48,052
| +6% | +$1.48M |
|
309
Martin Marietta Materials
MLM
$34.2B
| $28.1M | 0.07% |
128,696
+3,529
| +3% | +$778K |
|
310
Expedia Group
EXPE
$36.5B
| $28M | 0.07% |
221,843
+3,795
| +2% | +$463K |
|
311
NOV
NOV
$6.84B
| $27.6M | 0.06% |
687,462
+24,749
| +4% | +$964K |
|
312
Church & Dwight Co
CHD
$23.7B
| $27.4M | 0.06% |
550,072
+35,930
| +7% | +$1.72M |
|
313
Lincoln National
LNC
$7.92B
| $27.4M | 0.06% |
418,188
+11,163
| +3% | +$763K |
|
314
Huntington Bancshares
HBAN
$34B
| $27.2M | 0.06% |
2,030,022
+59,866
| +3% | +$818K |
|
315
ResMed
RMD
$31.1B
| $27M | 0.06% |
375,691
+15,971
| +4% | +$1.1M |
|
316
Mohawk Industries
MHK
$6.91B
| $26.8M | 0.06% |
116,841
+1,950
| +2% | +$429K |
|
317
McCormick & Company Non-Voting
MKC
$14B
| $26.8M | 0.06% |
549,688
+22,842
| +4% | +$1.11M |
|
318
Henry Schein
HSIC
$9.78B
| $26.7M | 0.06% |
401,184
+20,245
| +5% | +$1.32M |
|
319
CMS Energy
CMS
$23B
| $26.7M | 0.06% |
595,949
+54,497
| +10% | +$2.36M |
|
320
American Water Works
AWK
$27B
| $26.6M | 0.06% |
342,129
+8,014
| +2% | +$595K |
|
321
Bread Financial
BFH
$4.32B
| $26.3M | 0.06% |
132,096
+2,291
| +2% | +$433K |
|
|
COL
322
DELISTED
Rockwell Collins
COL
| $26.3M | 0.06% |
270,187
+8,182
| +3% | +$769K |
|
323
Viatris
VTRS
$20.8B
| $26M | 0.06% |
666,576
+21,872
| +3% | +$882K |
|
324
Best Buy
BBY
$19B
| $26M | 0.06% |
528,126
+11,327
| +2% | +$506K |
|
325
Host Hotels & Resorts
HST
$17.5B
| $25.9M | 0.06% |
1,386,904
+86,305
| +7% | +$1.58M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.